<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04555798</url>
  </required_header>
  <id_info>
    <org_study_id>ICU-44-20</org_study_id>
    <nct_id>NCT04555798</nct_id>
  </id_info>
  <brief_title>Effect of Arterio-venous ECMO on Severe Sepsis and ARDS</brief_title>
  <official_title>The Immunoadsorption Effect of Arterio-venous ECMO in Refractory Septic Shock With ARDS Following Severe Lung Contusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Gaber Allam</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Abdul Aziz Specialist Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King Abdul Aziz Specialist Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate and compare the effect of immunoadsorption effect of A-V ECMO on course of sepsis&#xD;
      weaning from inotropes, weaning from the ventilator, duration of ICU stays and effect on&#xD;
      mortality rate in patients with septic shock and respiratory failure due to ARDS followed&#xD;
      severe lung contusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      100 patients with respiratory failure without improvement after 10 days ventilation due to&#xD;
      development of VAP with ARDS, had &gt;2 SOFA score and &gt;6 CPIS score included in two groups 50&#xD;
      patients in each. Only patients of group B put on A-V ECMO while patients of group A continue&#xD;
      on traditional way of management. Improvement of ARDS &amp;VAP, weaning from ventilation,&#xD;
      duration of ICU stays, improvement of one/all parameters of both SOFA and CPIS scores,&#xD;
      morbidity and mortality recorded and compared within 14 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>100 patients from those who showed no improvement after 10 days ventilation and still had respiratory failure and in need of high ventilatory parameters (as mentioned before), fulfilled &gt; 2 parameters on SOFA score as illustrated in table (2), &gt; 6 on CPIS score as illustrated in table (3) and developed circulatory failure (septic shock) with nor-adrenaline infusion and only on high dose of nor-adrenaline included in our study (&gt;5microgram/kg/minute intravenous infusion as circulatory support). Since the parameters of those 100 patients selected are considered indication for arteriovenous extracorporeal membranous (A-V ECMO), so patients randomly allocated in two groups 50 patients in each. Randomization sequence was created using Excel 2007 (Microsoft, Redmond, WA, USA) with a 1:1 allocation using random block sizes of 2 and 4 by an independent doctor. In this way, sequence generation and type of randomization can be expressed at the same time</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients weaned from ventilators</measure>
    <time_frame>2 weeks</time_frame>
    <description>who showed improvement in CPIS score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of patients disharged from ICU</measure>
    <time_frame>2 weeks</time_frame>
    <description>who successfully weaned from the ventilator and complete 24 hours observation without symptoms</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Patients With Respiratory Failure and Shocked</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group A continue on the same conventional way of management as mentioned above with conventional way of ventilation and broad spectrum antibiotics coverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group B who connected to (A-VECMO).with venous access from femoral vien and arterial cannulation using the femoral artery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meropenem Injection</intervention_name>
    <description>patients of both groups given meropenam 1 gram every 8 hours till we collect the sputum culture</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A-V ECMO</intervention_name>
    <description>Only patients of group B connected to A-V ECMO for two weeks</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those who had an age between 18-65 years old&#xD;
&#xD;
          -  patients ventilated for more than 10 days&#xD;
&#xD;
          -  with conscious level more than 8/15 on Glasgow Coma Scale&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        pediatric patients below 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>King abd el Aziz specialist hospital</name>
      <address>
        <city>Ta'if</city>
        <zip>21944</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>October 17, 2020</last_update_submitted>
  <last_update_submitted_qc>October 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>King Abdul Aziz Specialist Hospital</investigator_affiliation>
    <investigator_full_name>Mohamed Gaber Allam</investigator_full_name>
    <investigator_title>Consultant intensivist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meropenem</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>only after publishing the work in specific journal</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

